Yves Bikorimana։ Normal MCV Doesn’t Always Mean Normal RBCs
Yves Bikorimana, CEO at MedData – Rwanda and Lab Scientist at The University Teaching Hospital of Kigali – Chuk, shared a post on LinkedIn:
”A normal Mean Corpuscular Volume (MCV) does not always mean the red blood cells are actually normal in size.
What’s happening here?
MCV measures the average size of red blood cells (RBCs).
In the image:
- One side has small cells (microcytes)
- The other side has large cells (macrocytes)
When you average them together, the result can appear ‘normal’
So the lab value says ‘normal MCV,’ but in reality, there is a mixed population of abnormal cells.
This phenomenon is called:
Anisocytosis: meaning variation in red blood cell sizes.
Why does this matter clinically?
A normal MCV can hide underlying disease, such as:
- Combined deficiencies:
Iron deficiency – small cells
Vitamin B12 or folate deficiency – large cells
- Recent blood transfusion (mix of donor and patient cells)
- Certain bone marrow disorders
How do we detect the ‘different reality’?
We don’t rely on MCV alone. We also look at:
- Red Cell Distribution Width (RDW)
Measures variation in RBC size
High RDW = mixed population (like in the image)
- Peripheral blood smear
Directly shows the mix of small and large cells
Key takeaway:
- A normal average (MCV) can be misleading.
- Always interpret it alongside RDW and blood smear findings.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 13:46Sergio Emanuel Kaiser: A Whole New Array of Potent Oral PCSK9 Inhibitors
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke